Marker Therapeutics, Inc. (MRKR) vs P3 Health Partners Inc. (PIII)
A side-by-side comparison of Marker Therapeutics, Inc. and P3 Health Partners Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRKR
Marker Therapeutics, Inc.
$1.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PIII
P3 Health Partners Inc.
$5.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRKR vs PIII
growth of $100 · dividends reinvested · last 5yMRKR -94.9% (-44.8%/yr)PIII -98.7% (-58.2%/yr)MRKR compounded faster over this window
MRKR PIII
MRKR vs PIII: by the numbers
- •PIII is the larger company ($18M vs $17M market cap).
- •Both run net losses; PIII's is the smaller (-6.55% vs -706.23% net margin).
Metrics side by side
Valuation
| Metric | MRKR | PIII |
|---|---|---|
| P/S ratio | 13.66 | 0.01 |
| P/B ratio | 1.38 | N/A |
Profitability
| Metric | MRKR | PIII |
|---|---|---|
| Gross margin | 0.00% | -9.89% |
| Operating margin | 0.00% | -18.53% |
| Net margin | -706.23% | -6.55% |
| ROE | -71.57% | -136.36% |
| ROIC | -88.07% | -51.68% |
Growth (annualized)
| Metric | MRKR | PIII |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 22.04% |
| Total return CAGR (5Y) | -42.13% | -58.41% |
Frequently asked
- How have MRKR and PIII total returns compared?
- Over the past 5 years, MRKR delivered -42.13% and PIII delivered -58.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Marker Therapeutics ROEP3 Health Partners ROEMarker Therapeutics operating marginP3 Health Partners operating marginMarker Therapeutics revenue growthP3 Health Partners revenue growthMarker Therapeutics free cash flowP3 Health Partners free cash flow
Marker Therapeutics & P3 Health Partners appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.